Will Robinhood Win Tokenization?
For many years, cryptocurrency enthusiasts have predicted a mass tokenization…
Sell
42
DRUG Quote, Financials, Valuation and Earnings
Last price:
$57.01
Seasonality move
:
-8.96%
Day range:
$56.27 - $60.43
52-week range:
$23.18 - $70.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.80x
Volume:
207.3K
Avg. volume:
169.3K
1-year change:
34.78%
Market cap:
$410.4M
Revenue:
--
EPS (TTM):
-$0.94
Earnings Data
Next earnings date for DRUG
Dec 22
2025
Most recent earnings per share
-$0.53
Beat by $0.11
(Aug 14/2025)
Consensus Estimate
-$0.65
(Aug 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$0.87 | -- |
| 12/22/2025 | Q3 | -- | -- | -- | -$0.69 | -- |
| 08/14/2025 | Q2 | -- | -- | -$0.53 | -$0.65 | $0.11 |
| 05/15/2025 | Q1 | -- | -- | -$0.29 | -$0.33 | $0.04 |
| 02/13/2025 | Q4 | -- | -- | $0.01 | -$0.35 | $0.35 |
| 09/30/2024 | Q3 | -- | -- | -$0.13 | -$0.43 | $0.30 |
| 06/30/2024 | Q2 | -- | -- | $0.04 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.76 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.96 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.22 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.64 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.45 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences, Inc. Earnings Questions
-
How Much did Bright Minds Biosciences, Inc. Generate in Revenue Last Quarter?
Bright Minds Biosciences, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences, Inc. Beat Earnings Last Quarter?
Bright Minds Biosciences, Inc. announced earnings per share of -$0.53 which represents a beat of analyst forecast a -$0.65 per share.
-
Is Bright Minds Biosciences, Inc. Profitable?
Bright Minds Biosciences, Inc. reported -$11.4K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences, Inc. EPS Next Year?
Bright Minds Biosciences, Inc.'s earnings are forecast to decrease from -$0.48 per share to -$1.63 per share next year representing a decrease of -827.96%.
-
When is Bright Minds Biosciences, Inc.'s Earnings Date?
Bright Minds Biosciences, Inc.'s next earnings date is December 22, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does DraftKings Stock Have a Moat?
DraftKings (NASDAQ:DKNG) has been one of the largest beneficiaries of…
Is It Time To Buy Unity Stock?
Unity Software (NYSE:U) is the business behind the popular Unity…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
62
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 37x
Alerts
Buy
88
CDTX alert for Nov 15
Cidara Therapeutics, Inc. [CDTX] is up 105.38% over the past day.
Buy
60
SRRK alert for Nov 15
Scholar Rock Holding Corp. [SRRK] is up 24.38% over the past day.
Buy
86
ZCSH alert for Nov 15
Grayscale Zcash Trust (ZEC) [ZCSH] is up 21.52% over the past day.
